Abstract
A 73-year-old woman was admitted to hospital with fever whilst under treatment with infliximab for rheumatoid arthritis. Despite repeated and specific testing, tuberculosis was only diagnosed post mortem. During infliximab therapy, latent tuberculosis can reactivate in subacute form with a possible fatal outcome. For infliximab therapy to be administered safely, the risk that the patient concerned is latently infected with tuberculosis has to be estimated beforehand; if necessary a prophylactic anti-tuberculosis treatment may be given.
Translated title of the contribution | Fatal extrapulmonary tuberculosis during treatment with the immunosuppresive infliximab |
---|---|
Original language | Dutch |
Pages (from-to) | 1196-1199 |
Number of pages | 4 |
Journal | Nederlands tijdschrift voor geneeskunde |
Volume | 146 |
Issue number | 25 |
Publication status | Published - 22 Jun 2002 |
Externally published | Yes |